Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Friedmann

Showing results (21-30 of 261) with videos related to

Pageof 27
Sort By:
The New England Journal of Medicine|March 9, 2017
How ACA Repeal Would Worsen the Opioid EpidemicPeter D Friedmann, Christina M Andrews, Keith Humphreys
Journal of Substance Abuse Treatment|May 19, 2007
Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United StatesPeter D Friedmann, Lan Jiang, Kimber P Richter
Substance Abuse|September 2, 2020
Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disordersEkaterina Pivovarova, Hye Sung Min, Peter D Friedmann
JAMA Network Open|September 27, 2024
Precipitated Withdrawal in the Era of Street Fentanyl-The Important Thing Is to Not Stop QuestioningWilliam E Soares, Elizabeth Schoenfeld, Peter D Friedmann
Drug and Alcohol Dependence|January 22, 2022
Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorderElizabeth A Evans, Donna Wilson, Peter D Friedmann
The New England Journal of Medicine|November 26, 1992
Continued zidovudine or didanosine for human immunodeficiency virus infectionR Saitz, P D Friedmann, M S Roberts
Journal of General Internal Medicine|November 26, 2005
Buprenorphine retention in primary careMichael D Stein, Patricia Cioe, Peter D Friedmann
Drug and Alcohol Dependence|July 27, 2001
Social relationships and intravenous drug use among methadone maintenance patientsA Gogineni, M D Stein, P D Friedmann
The Journal of Behavioral Health Services & Research|March 20, 2009
Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programsPeter D Friedmann, Lan Jiang, Jeffrey A Alexander
Journal of Addictive Diseases|September 28, 2005
Physician attitudes regarding the prescription of medical marijuanaAnthony Charuvastra, Peter D Friedmann, Michael D Stein
Pageof 27

Showing results (21-30 of 261) with videos related to

Sort By:
Pageof 27
The New England Journal of Medicine|March 9, 2017
How ACA Repeal Would Worsen the Opioid EpidemicPeter D Friedmann, Christina M Andrews, Keith Humphreys
Journal of Substance Abuse Treatment|May 19, 2007
Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United StatesPeter D Friedmann, Lan Jiang, Kimber P Richter
Substance Abuse|September 2, 2020
Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disordersEkaterina Pivovarova, Hye Sung Min, Peter D Friedmann
JAMA Network Open|September 27, 2024
Precipitated Withdrawal in the Era of Street Fentanyl-The Important Thing Is to Not Stop QuestioningWilliam E Soares, Elizabeth Schoenfeld, Peter D Friedmann
Drug and Alcohol Dependence|January 22, 2022
Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorderElizabeth A Evans, Donna Wilson, Peter D Friedmann
The New England Journal of Medicine|November 26, 1992
Continued zidovudine or didanosine for human immunodeficiency virus infectionR Saitz, P D Friedmann, M S Roberts
Journal of General Internal Medicine|November 26, 2005
Buprenorphine retention in primary careMichael D Stein, Patricia Cioe, Peter D Friedmann
Drug and Alcohol Dependence|July 27, 2001
Social relationships and intravenous drug use among methadone maintenance patientsA Gogineni, M D Stein, P D Friedmann
The Journal of Behavioral Health Services & Research|March 20, 2009
Top manager effects on buprenorphine adoption in outpatient substance abuse treatment programsPeter D Friedmann, Lan Jiang, Jeffrey A Alexander
Journal of Addictive Diseases|September 28, 2005
Physician attitudes regarding the prescription of medical marijuanaAnthony Charuvastra, Peter D Friedmann, Michael D Stein
Pageof 27